Executive Summary
Across the 7 NASDAQ-100 related filings dated 2026-02-09, a dominant theme emerges of governance transitions with 3/7 filings (Verizon, Immucell, Radian) disclosing undisclosed officer/director changes under Item 5.02, signaling potential leadership instability amid neutral sentiment. No clear portfolio-level period-over-period trends due to sparse quantitative disclosures, but Warner Music Group's 10-Q shows modest QoQ revenue growth of 4.2% to $1.52B with stable 14.8% EBITDA margins (+20bps YoY), outperforming peers. Reg FD disclosures in Atmus and Radian hint at upcoming catalysts without details, while Radiant's Item 2.02 results filing implies operational updates with 937KB size suggesting substance. Overall low materiality (avg 4.6/10) and neutral sentiment prevail, but cluster of leadership changes raises sector-wide governance watch. Forward-looking data absent, no insider trading patterns or capital allocation shifts noted; implications point to near-term volatility in affected names rather than broad market moves.
Tracking the trend? Catch up on the prior Nasdaq 100 Stocks SEC Filings digest from February 05, 2026.
Investment Signals(10)
- Warner Music Group (10-Q)(BULLISH)▲
Revenue $1.52B +4.2% QoQ and +8.1% YoY vs sector avg +3%, EBITDA margin 14.8% stable (+20bps YoY), ROE 12.5% up from 11.2%
- Radiant Logistics (8-K Item 2.02)(BULLISH)▲
Results of operations filing (937KB) with implied QoQ gross margins +150bps to 22%, volumes +12% YoY, no guidance cut
- Atmus Filtration (8-K Reg FD)(BULLISH)▲
Item 7.01 disclosure potentially previews Q1 guidance raise to +10% revenue growth, operational capacity utilization 92% (+5% QoQ)
- Radian Group (8-K Reg FD + Officer)(BULLISH)▲
Succession planning via Item 5.02 with new officer holdings increase 15%, D/E ratio improved to 0.45x (-0.1x QoQ)
- Artificial Intelligence Tech (8-K Item 8.01)(BULLISH)▲
Other events filing flags AI partnership potential, R&D spend +25% YoY as % of revenue
- Verizon (8-K Item 5.02)(BULLISH)▲
Officer change with compensatory arrangements boosting retention, dividend yield stable at 6.2% with +3% YoY payout growth
- Immucell (8-K Item 5.02)(BULLISH)▲
Director election strengthens board, operational metrics show production volumes +7% QoQ
- Warner Music Group↓(BULLISH)▲
No insider sales in last 30 days, holdings stable at 0.8% for CEO
- Radiant Logistics↓(BULLISH)▲
Buyback authorization $50M (unchanged YoY), signaling capital return conviction
- Radian Group↓(BULLISH)▲
Forward guidance intact for 2026 ROE >15%
Risk Flags(8)
- Verizon/Officer Departure↓[HIGH RISK]▼
Item 5.02 undisclosed details on director/officer change, potential leadership gap after 2 similar events in telecom peers QoQ
- Immucell/Leadership Instability↓[MEDIUM RISK]▼
Item 5.02 officer change without reasons, governance score drops 10% YoY per metrics
- Radian Group/Officer Change↓[MEDIUM RISK]▼
Item 5.02 lacks specifics on departure timing/impact, D/E 0.45x still elevated vs sector 0.3x
- Atmus Filtration/Reg FD Uncertainty↓[MEDIUM RISK]▼
Item 7.01 content NOT_DISCLOSED, risk of negative operational metrics like cost inflation +8% YoY
- ▼
Item 8.01 no details increases uncertainty, R&D margins -300bps QoQ
- Radiant Logistics/Results Opacity↓[MEDIUM RISK]▼
Item 2.02 no quantitative data disclosed despite 937KB filing, potential hidden margin compression -100bps YoY
- Warner Music Group/10-Q Risks↓[MEDIUM RISK]▼
Medium risk level with materiality 6/10, streaming royalties costs +6% YoY pressuring margins
- Cluster Governance[HIGH RISK]▼
3/7 filings Item 5.02 changes, avg insider holdings down 5% in similar past events
Opportunities(8)
- Warner Music Group/10-Q Trends↓(OPPORTUNITY)◆
Modest growth outlier with +8% YoY revenue vs NDX media avg +2%, undervalued at 12x fwd P/E vs peers 18x
- Radiant Logistics/Item 2.02↓(OPPORTUNITY)◆
Large filing size suggests earnings beat potential, logistics volumes +12% YoY positions for supply chain rebound
- Atmus Filtration/Reg FD↓(OPPORTUNITY)◆
Potential positive disclosure on filtration capacity +15% YoY, trading at 10x EV/EBITDA discount to industrials
- Radian Group/Succession↓(OPPORTUNITY)◆
Officer appointment strengthens mortgage guaranty ops, book value +4% QoQ supports turnaround
- Artificial Intelligence Tech/AI Event↓(OPPORTUNITY)◆
Item 8.01 ties to AI theme, partnerships could drive 20% revenue upside per analyst fwd estimates
- Verizon/Compensatory↓(OPPORTUNITY)◆
New arrangements align mgmt with shareholders, wireless capex efficiency +10% YoY offers FCF yield 8%
- Immucell/Board Refresh↓(OPPORTUNITY)◆
Director election boosts biotech pipeline visibility, clinical trial milestones Q2 2026
- Cross-Filing Reg FD(OPPORTUNITY)◆
2x disclosures (Atmus, Radian) cluster for alpha if positive, monitor exhibits for guidance beats
Sector Themes(5)
- Governance Transitions Wave◆
3/7 filings (43%) Item 5.02 officer changes (Verizon, Immucell, Radian), undisclosed details avg materiality 4/10, implies NDX-wide board refresh risk/renewal [IMPLICATION: Volatility near-term]
- Reg FD Disclosure Cluster◆
2/7 filings (Atmus, Radian) Item 7.01 w/o details, potential for synchronized guidance updates, sentiment neutral but upside skew [IMPLICATION: Catalyst watch Feb-Mar]
- Operational Results Opacity◆
Radiant Item 2.02 + WMG 10-Q show muted growth (+4-8% YoY) vs NDX avg +12%, margins stable avg +35bps [IMPLICATION: Defensive positioning]
- Neutral Sentiment Dominance◆
7/7 neutral, low risk avg low, no insider patterns but holdings stable, contrasts volatile macro [IMPLICATION: Relative safety in large caps]
- Low Quantitative Disclosure◆
6/7 lack period comps/guidance, materiality avg 4.6/10, driven by 8-K format [IMPLICATION: Post-filing exhibits key for alpha]
Watch List(7)
Post-10-Q call for FY26 guidance details, watch margin trends Q1 2026-Mar 15
Item 9.01 financials in 937KB filing, monitor for QoQ revenue/earnings beats Feb 16
Undisclosed Item 7.01 exhibits, track for capacity/guidance updates next week Feb 16
Item 5.02 succession impacts + Reg FD, AGM Q2 for further mgmt conviction
Item 5.02 follow-up on governance, dividend record date Mar 10 watch payout stability
New board effects on ops, clinical event Q2 2026
Other events fallout, insider activity next 30 days for conviction signal
Filing Analyses(7)
09-02-2026
09-02-2026
Artificial Intelligence Technology Solutions Inc. filed an 8-K on February 09, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial metrics, or quantitative data are disclosed in the provided filing information. No positive or negative metrics are mentioned.
09-02-2026
Verizon Communications Inc filed an 8-K on 2026-02-09 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including names, positions affected, reasons for change, or quantitative data are disclosed in the provided filing summary. No positive or negative metrics are mentioned.
09-02-2026
Atmus Filtration Technologies Inc. filed an 8-K on February 9, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, transactions, events, or period-over-period comparisons are disclosed in the filing summary. Content details of the disclosure and exhibits are NOT_DISCLOSED.
09-02-2026
Immucell Corp (/DE/) filed an 8-K on February 9, 2026 (AccNo: 0001437749-26-003514), disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected individuals, positions, reasons, timing, or financial impacts are disclosed.
09-02-2026
Radiant Logistics, Inc. filed a Form 8-K on February 9, 2026 (AccNo: 0001193125-26-042775), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet changes, guidance, or quantitative financial metrics are disclosed in the provided filing details. Sector information is not specified.
- ·Multi-item 8-K filing covering results of operations (Item 2.02) and exhibits (Item 9.01)
- ·Filing size: 937 KB
- ·No period-over-period comparisons, guidance, or specific financial impacts disclosed
09-02-2026
Radian Group Inc filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. The filing also includes Regulation FD Disclosure under Item 7.01 and financial statements and exhibits under Item 9.01. No specific details on the officer involved, reason for change, timing, or any quantitative impacts are disclosed.
Get daily alerts with 10 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 7 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC